Mitos y evidencias en el empleo de la toxina botulínica: neurofarmacología y distonías

Volume: 66, Issue: 05, Pages: 163 - 163
Published: Jan 1, 2018
Abstract
Botulinum toxin type A (BTA) is a bacterial endotoxin, whose therapeutic use has had a dramatic impact on different neurological disorders, such as dystonia and spasticity.To analyze and summarize different questions about the use of BTA in our clinical practice.A group of experts in neurology developed a list of topics related with the use of BTA. Two groups were considered: neuropharmacology and dystonia. A literature search at PubMed, mainly...
Paper Details
Title
Mitos y evidencias en el empleo de la toxina botulínica: neurofarmacología y distonías
Published Date
Jan 1, 2018
Volume
66
Issue
05
Pages
163 - 163
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.